Binnopharm Group is the most digitalized pharmaceutical company according to Digital Excellence Awards 2023

Binnopharm Group won four nominations at once in the first annual open competition in the pharmaceutical industry Digital Excellence Awards 2023.

The leaders were announced on November 15, 2023. Binnopharm Group won in the categories «The Most Digitalized Pharmaceutical Company», «The Best Data Strategy in an Advertising Campaign» (Venarus®), «The Best Technological Solution in Digital Advertising» (Kagocel®), «Viral Creatives and Non-Standard Solutions» (Albendazole-ALIUM).

Ekaterina Slavgorodskaya, Sales and Promotion Director of Binnopharm Group: «Binnopharm Group is the leading player in the Russian pharmaceutical market. As a company striving for leadership, we want to be pioneers in everything, including promotion. Therefore, the team is focused on creating an effective system of omnichannel promotion and digitalization of consumer campaigns. This approach has borne fruit. Every month we show not only the highest growth dynamics among the top 10 pharmaceutical corporations in the country, but also a steady rise in the retail sales ranking. But perhaps the most importantly, our products are highly recognized and in demand among doctors and patients».

The Digital Excellence Awards are the most important awards in the industry, where employees of pharmaceutical companies, an expert jury consisting of pharmaceutical companies’ representatives, digital, analytical agencies and e-commerce, as well as SFE & Marketing Excellence Academy select the best cases.